OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 181 - 190 of 796 studies

Cancer and neoplasms

A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma (BEACON2)

Despite advances with the introduction of anti-GD2 immunotherapy,there is a major unmet need to develop new drugs for treatment of high-risk neuroblastoma. Around half of patients relapse despite intensive therapies,and outcome following relapse is dismal (<10% long term survival). The BEACON2 trial will confirm which combination of drugs tested in the phase II BEACON study should be taken forward and identify novel combinations that further improve survival in this patient group. Based on our experience in a previous trial (BEACON),the ...

GO TO STUDY Go

Infection

A Phase II, Multicentre, Double-blind, Randomised, Controlled Study of a Bivalent Conjugate Vaccine against Salmonella enterica serovar Typhi and Paratyphi A to evaluate the Efficacy, Immunogenicity and Safety using a Human Challenge Model of Paratyphoid A Infection. (BiVISTA)

This is a multicentre,double blinded,randomised,active-controlled study of a novel vaccine SII-TCV(B) against typhoid and paratyphoid A infection,using a healthy adult participant controlled human challenge model of paratyphoid A infection compared with a licensed Vi-polysaccharide vaccine against typhoid infection (Typhim Vi). The aim is to assess the efficacy of SII-TCV(B) against S. Paratyphi A using the challenge model and to demonstrate the non-inferiority of the immune response to the S. Typhi component of SII-TCV(B),when compared to Typhim Vi. In total,192 participants will ...

GO TO STUDY Go

Cancer and neoplasms

Studying Treatments in patients receiving androgen deprivation therapy (ADT) and androgen receptor signalling inhibitors (ARSI) for Metastatic Prostate Cancer: Evaluation of Drug and radiation Efficacy: A 2nd multi-arm multi-stage randomised controlled trial (STAMPEDE2).

This is a platform trial testing the addition of experimental treatments to standard of care (SoC) with two randomised controlled trials called research comparisons. The platform design allows the addition of other research treatments into the structure following protocol amendment. The primary objectives of each comparison are to test whether survival and/or cancer outcomes can be improved by the addition of the research treatments to SoC in men with metastatic prostate cancer and starting long-term androgen deprivation therapy. Key secondary objectives ...

GO TO STUDY Go

Musculoskeletal

Randomised Controlled Trial of Short and Conventional Length Cemented Total Hip Replacement (SCoFS)

Total hip arthroplasty (THA) is one of the most commonly performed and most successful orthopaedic operations. A THA procedure involves implanting a prosthetic stem & cup into the femur and acetabulum respectively. The implants can be secured to the host bone in two ways; with bone cement (a cemented implant) or by relying upon bone growth into or onto the implant (an uncemented implant). Several design features of THA implants have been areas of research interest, aimed at improving outcomes, ...

GO TO STUDY Go

Infection Inflammatory and immune system

Sepsis Trials in Critical Care (SepTiC)

Design: A 2x2 factorial pragmatic open-label randomised controlled trial,with an embedded randomised double-blind parallel group trial Setting: 60 general ICUs in the UK Target population: Adult patients who are critically ill due to sepsis Inclusion criteria - Adult patients admitted to ICU due to suspected sepsis and expected to stay for at least 48 hours - Receiving intravenous antibiotics for suspected sepsis - Initial early fluid resuscitation complete - Acute organ dysfunction due to infection Additional criteria for GM-CSF subset - Mechanically ventilated - Receiving vasopressors/inotropes - Absolute lymphocyte count <1.2 ...

GO TO STUDY Go

Infection Reproductive health and childbirth

Transcriptomic and Immunological signatures associated with Neurodevelopmental outcomes in Infants with Congenital Cytomegalovirus. (TINI-CC)

Cytomegalovirus (CMV), the international leading cause of neurodevelopmental impairment from infection acquired during pregnancy, is estimated to affect over 4200 babies and cost over £750 million each year in the UK. CMV is a common virus usually causing mild infection in healthy individuals, however CMV can cause serious disease if it affects a baby during pregnancy. Only the most severely affected cases of CMV acquired in pregnancy tend to be identified by healthcare professionals because there is currently no screening ...

GO TO STUDY Go

Cancer and neoplasms Oral and Gastrointestinal

Abbreviated Magnetic Resonance Imaging vs ultrasound surveillance for liver cancer detection in people at high risk of developing liver cancer (AMULET)

People with any condition that affects the liver over a long period of time can develop cirrhosis. Conditions that can lead to cirrhosis include alcohol excess, liver steatosis (lipid or fat accumulation in the liver) and infection with hepatitis B and C. One concern about people with cirrhosis is that they are at increased risk of developing liver cancer. People with cirrhosis are recommended to have an ultrasound scan (USS) every 6 months (surveillance) so that if a cancer develops, ...

GO TO STUDY Go

Musculoskeletal

Musculoskeletal Atlas of Paediatric tissue (MAP)

Our musculoskeletal system is essential for movement and to give our body structure. The system is made up of bones (skeleton) and soft connective tissues (muscles, tendons, cartilage and ligaments )that enable the skeleton to move. These tissues contain cells that work together to help the tissue function and grow normally. Our musculoskeletal system changes continuously from infancy to adulthood, with each tissue type changing in both size and shape, and they become less effective at repairing themselves when injured. Our ...

GO TO STUDY Go

Neurological

Spinal Cord Stimulation for Gait Dysfunction in Parkinson's Disease (SCORE-PD)

Parkinson's disease (PD) is the second commonest neurodegenerative disorder, affecting over 145,000 people in the UK. Initially, PD patients experience slowness of movements, limb stiffness, and tremor. With progressive loss of neurons over time, many patients start to experience balance and walking problems, and falls, which are resistant to currently available treatments. Falls can lead to fractures and nursing home admission, and can significantly shorten patients' life expectancy. In this pilot study, we will investigate the effects of spinal ...

GO TO STUDY Go

Cancer and neoplasms

DRAGON 2 – An international multicenter randomized controlled trial to compare combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE alone. (DRAGON 2)

Resection of liver metastases from colorectal cancer (CRLM) improves survival compared to chemotherapy alone and may lead to cure. In some cases the liver metastasis are considered unresectable. A common reason for this is the lack of enough "tumour free" liver for the patient to survive the operation (Future liver remnant -FLR-). In the event of insufficient FLR, there is a great proportion of patients that will develop liver disfunction that can lead to death (post-hepatectomy liver failure is the ...

GO TO STUDY Go